Race & Ethnicity Mortality Equity Benchmark (OMB-97 Series)
A benchmarking data product delivering time-consistent U.S. death rates by race and Hispanic origin under the 1997 OMB standards, with a reconciliation layer for the pre-2018 bridged-race break, so payers and health systems can track disparity gaps against a stable national baseline.
Concept
A data product for health systems, Medicaid-focused payers, and health departments. It delivers annual U.S. death rates stratified by race and Hispanic origin — computed under the 1997 Office of Management and Budget standards that current NCHS reports use — packaged with (1) disparity-gap metrics (rate ratios between groups) and (2) a reconciliation layer that documents the discontinuity versus the bridged-race categories used in reports before 2018. Delivered as tables/API, it lets an organization compare the mortality of its own member or patient populations by race/ethnicity against a consistent national baseline without misreading the 2018 standards change.
Why now
The 2024 final report presents death rates by race and Hispanic origin under the 1997 OMB standards and explicitly notes these differ from the bridged-race categories shown in reports for data years before 2018 [0]. Any organization trending racial mortality disparities across time faces a series break at 2018; the new final 2024 data extend the consistent OMB-97 series, making a standardized, forward-consistent equity benchmark both feasible and necessary for payers and systems with health-equity reporting commitments.
Written by GLM · 2 Oct 2026
AI assessment
A highly focused data product that solves a specific, technical pain point (the 2018 data break) for health-equity reporting in a high-stakes regulatory environment.
- Evidence strength 5/5
- The idea is directly derived from the NCHS 2024 report's explicit warning about the 2018 standards change, making the 'reconciliation layer' a necessary technical solution to a documented data problem.
- Market pull 4/5
- Payers and health systems are under increasing regulatory and ESG pressure to report health equity metrics, creating a strong pull for standardized, time-consistent benchmarks.
- Novelty & moat 4/5
- While other ideas use mortality tables for pricing (ParadoxBasis), this focuses on the longitudinal equity gap and the specific technical reconciliation of OMB standards, filling a distinct gap.
- Feasibility 5/5
- The MVP requires aggregating existing public NCHS/CDC WONDER data and applying a documented reconciliation logic, which is a low-complexity data engineering task.
- Wedge clarity 5/5
- The wedge is extremely sharp: solving the '2018 series break' for health-equity officers who cannot otherwise trend their disparity gaps accurately.
- Simplicity / focus 5/5
- The product is a single, well-defined data feed/API with one clear purpose, avoiding the 'platform' trap.
Scored by Gemma 4 · 14 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.
Persona discussion
AI personas trained on real people's expertise debate this idea as it evolves.
View the discussion →Act on this idea
Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.
Business analysis
The PESTEL analysis reveals a strong alignment with current US healthcare policy and social mandates for health equity, though it faces a critical technical challenge in reconciling the 2018 data break. The product's viability depends on its ability to transform fragmented public NCHS data into a high-value, time-consistent benchmark for regulated payers.
Political2
Economic2
Social2
Technological2
Environmental2
Legal2
The product's viability is directly tied to government standards (OMB), healthcare regulations, and the societal push for health equity reporting. · Generated 2026-10-14 by Gemma 4AI-generatedFull PESTEL Analysis →
Who benefits
- KFForganization
KFF's health disparity analyses communicate in years of life expectancy; an annually refreshed, decomposed gap series (e.g., the 4.5-year non-Hispanic black–white gap) feeds its equity tracking directly.
- Robert Wood Johnson Foundationorganization
RWJF funds programs aimed at closing life-expectancy gaps; age-band decomposition shows where a gap is generated, helping target grants by life stage rather than overall rates.
- Centenecompany
The largest Medicaid managed-care payer; equity reporting to state regulators requires disparity metrics measured against a stable national baseline, which a harmonized OMB-97 series provides.
- Kaiser Permanenteorganization
A large integrated health system with public health-equity commitments; consistent race/ethnicity mortality benchmarks let it measure member populations against national rates without the 2018 standards break distorting trends.
- CommonSpirit Healthorganization
The large nonprofit health system serves diverse communities under health-equity commitments; knowing which age bands drive local life-expectancy gaps directs its community-investment programs.
- Molina Healthcarecompany
A Medicaid-focused payer with government quality and equity reporting obligations; rate-ratio benchmarks by race/Hispanic origin support those deliverables with less internal data engineering.
- Elevance Healthcompany
As a major payer with value-based contracts, Elevance needs disparity metrics expressed in life-expectancy years to set equity targets with providers and track progress annually.
Research it builds on
- Mortality in the United States, 2024Jiaquan Xu, Sherry L Murphy, Kenneth D. Kochanek et al. · 2026 · 462 citationsAll ideas from this paper →
- Infant Mortality in the United States, 2024: Data From the Period Linked Birth/Infant Death FileDanielle Ely, Anne K. Driscoll · 2026 · 243 citationsAll ideas from this paper →
- Trends in U.S. Drug Overdose Deaths in Non-Hispanic Black, Hispanic, and Non-Hispanic White Persons, 2000–2015Meredith S. Shiels, Neal D. Freedman, David A. Thomas et al. · 2017 · 167 citationsAll ideas from this paper →
- United States Life Tables, 2024Elizabeth Arias, Jiaquan Xu, Betzaida Tejada-Vera · 2026 · 65 citationsAll ideas from this paper →
- Gender, Racial, and Geographical Disparities in Malignant Brain Tumor Mortality in the USAJia Yi Tan, Jia Yean Thong, Yong Hao Yeo et al. · 2024 · 5 citationsAll ideas from this paper →